Hopkins engineers have developed a method to prevent harmful viruses from entering the lungs, blocking the spread of COVID-19 and influenza with a nasal spray
Unlike the novel coronavirus, which has been shown to mutate slowly, strains of influenza virus have acquired a mutation that blocks antibodies from binding to a key viral protein, making vaccine development more complex